tirzepatide in ghana FDA Grants a New Indication for Obesity Management Zapbound Tirzepatide Injection Model Kit

Costly GLP-1 Drugs Are Rarely Covered for Weight Loss by Marketplace Plans

How To Qualify For Zepbound You can qualify for a prescription of Zepbound if you are an adult with obesity (BMI 30 kg/m2 or higher) or are overweight (BMI 27 kg/m2 or higher) with a weight-related medical condition such as hypertension, dyslipidemia, type 2 diabetes mellitus, obstructive sleep apnea, or cardiovascular disease

Hope for the future in Covid-19 Treatment: As a potential ray of hope, German researchers have developed mini-antibodies or nanoantibodies that are smaller than the antibodies naturally made by the immune system

Pharmacy benefit managers (PBMs), like CVS Caremark, are constantly evaluating drugs based on their clinical effectiveness, pricing, and rebates

In a move that is making waves across the healthcare industry, CVS Health has recently announced that it will remove Zepbound from the CVS Caremark formulary, effective July 1, 2025